These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 36193937)
1. International Practice Patterns in the Detection and Management of Arrhythmias in Patients With Hypertrophic Cardiomyopathy. Cheung M; Husain A; Du D; Li COY; Parker J; Weissler-Snir A; Geske JB; Ong K; Laksman Z J Am Heart Assoc; 2022 Oct; 11(19):e027385. PubMed ID: 36193937 [No Abstract] [Full Text] [Related]
2. Detect and define ventricular arrhythmia substrates in hypertrophic cardiomyopathy. Wang J; Chen X; Zhao S Eur Heart J; 2024 Jul; 45(26):2343-2344. PubMed ID: 38820199 [No Abstract] [Full Text] [Related]
3. Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients With Hypertrophic Cardiomyopathy. Wang W; Lian Z; Rowin EJ; Maron BJ; Maron MS; Link MS Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28314849 [TBL] [Abstract][Full Text] [Related]
5. Prognostic implications of nonsustained ventricular tachycardia morphology in high-risk patients with hypertrophic cardiomyopathy. Adduci C; Boldini F; Palano F; Musumeci B; De Lucia C; Russo D; Volpe M; Autore C; Francia P J Cardiovasc Electrophysiol; 2020 Aug; 31(8):2093-2098. PubMed ID: 32437006 [TBL] [Abstract][Full Text] [Related]
6. Usefulness of an Implantable Loop Recorder to Detect Clinically Relevant Arrhythmias in Patients With Advanced Fabry Cardiomyopathy. Weidemann F; Maier SK; Störk S; Brunner T; Liu D; Hu K; Seydelmann N; Schneider A; Becher J; Canan-Kühl S; Blaschke D; Bijnens B; Ertl G; Wanner C; Nordbeck P Am J Cardiol; 2016 Jul; 118(2):264-74. PubMed ID: 27265676 [TBL] [Abstract][Full Text] [Related]
7. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy. Gimeno JR; Tomé-Esteban M; Lofiego C; Hurtado J; Pantazis A; Mist B; Lambiase P; McKenna WJ; Elliott PM Eur Heart J; 2009 Nov; 30(21):2599-605. PubMed ID: 19689975 [TBL] [Abstract][Full Text] [Related]
8. Correlations between cardiac troponin I and nonsustained ventricular tachycardia in hypertrophic obstructive cardiomyopathy. Liu L; Liu S; Shen L; Tu B; Hu Z; Hu F; Zheng L; Ding L; Fan X; Yao Y Clin Cardiol; 2020 Oct; 43(10):1150-1159. PubMed ID: 32810305 [TBL] [Abstract][Full Text] [Related]
9. Arrhythmia Evaluation and Management. Jacobson JT Cardiol Clin; 2019 Feb; 37(1):55-62. PubMed ID: 30447716 [TBL] [Abstract][Full Text] [Related]
10. Effect of type 2 diabetes on cardiac arrhythmias in patients with obstructive hypertrophic cardiomyopathy. Wang S; Zhang K; He M; Guo H; Cui H; Wang S; Lai Y Diabetes Metab Syndr; 2024 Mar; 18(3):102992. PubMed ID: 38560956 [TBL] [Abstract][Full Text] [Related]
11. Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy. McLELLAN AJ; Ellims AH; Prabhu S; Voskoboinik A; Iles LM; Hare JL; Kaye DM; Macciocca I; Mariani JA; Kalman JM; Taylor AJ; Kistler PM J Cardiovasc Electrophysiol; 2016 May; 27(5):571-80. PubMed ID: 26840595 [TBL] [Abstract][Full Text] [Related]
12. Apical hypertrophic cardiomyopathy and arrhythmia in military pilots. Carter D; Pokroy R; Barenboim E; Azaria B; Goldstein L Aviat Space Environ Med; 2006 Apr; 77(4):459-61. PubMed ID: 16676661 [TBL] [Abstract][Full Text] [Related]
13. Obstructive sleep apnea is associated with nonsustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy. Wang S; Cui H; Song C; Zhu C; Wu R; Meng L; Yu Q; Huang X; Wang S Heart Rhythm; 2019 May; 16(5):694-701. PubMed ID: 30576881 [TBL] [Abstract][Full Text] [Related]
14. Rapid Device-Detected Nonsustained Ventricular Tachycardia in the Risk Stratification of Hypertrophic Cardiomyopathy. Viswanathan K; Suszko AM; DAS M; Jackson N; Gollob M; Cameron D; Spears D; Woo A; Rakowski H; Khurana M; Chauhan VS Pacing Clin Electrophysiol; 2016 Jul; 39(7):642-51. PubMed ID: 27027856 [TBL] [Abstract][Full Text] [Related]
15. [The diagnosis of arrhythmias in hypertrophic cardiomyopathy]. Lengfelder W; Senges J Dtsch Med Wochenschr; 1991 Aug; 116(35):1319-21. PubMed ID: 1879324 [No Abstract] [Full Text] [Related]
16. [Mid-ventricular obstructive hypertrophic cardiomyopathy associated with an apical aneurysm and sustained ventricular tachycardia: a case report]. Kono K; Higashi T; Hara K; Mori S; Ito I; Shinbo G; Anzai R; Yagi H; Tamano K; Horinaka S; Matsuoka H J Cardiol; 2001 Dec; 38(6):343-9. PubMed ID: 11806092 [TBL] [Abstract][Full Text] [Related]
17. [Management of metabolic cardiomyopathy and conduction defects in children]. Labarthe F; Paoli F; Chantepie A Arch Pediatr; 2009 Jun; 16(6):643-5. PubMed ID: 19541115 [No Abstract] [Full Text] [Related]
18. Cardiac troponin I is associated with non-sustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy. Zhou Y; Yu M; Yuan J; Liu S; Hu F; Yang Z; Cui J; Qiao S Heart Vessels; 2020 Jun; 35(6):876-885. PubMed ID: 31907598 [TBL] [Abstract][Full Text] [Related]
19. Management and outcome of hypertrophic obstructive cardiomyopathy in pregnant women: a case report. Assamti M; Bougrine R; Ismaili N; Ouafi NE Pan Afr Med J; 2021; 38():140. PubMed ID: 33912310 [TBL] [Abstract][Full Text] [Related]
20. Arrhythmias and sudden death in hypertrophic cardiomyopathy. McKenna WJ; Firoozi S; Sharma S Card Electrophysiol Rev; 2002 Feb; 6(1-2):26-31. PubMed ID: 11984011 [No Abstract] [Full Text] [Related] [Next] [New Search]